Full-Time

Full Stack Data Engineer

Posted on 7/2/2025

Synapticure

Synapticure

51-200 employees

24/7 telehealth neurology for neurodegenerative care

No salary listed

Chicago, IL, USA

Remote

Category
Software Engineering (1)
Required Skills
Power BI
SQL
Machine Learning
Tableau
AWS
Looker
Data Analysis
Snowflake
Google Cloud Platform
Requirements
  • Proven experience driving decision-making as a Data Engineer or similar role
  • Experience working with CMS, clinical, or healthcare data
  • Strong SQL skills and experience with the modern data stack (e.g., dbt, Snowflake, Looker)
  • Proficiency with data visualization tools (e.g., Knowi, Tableau, Power BI, Looker)
  • Experience applying machine learning to healthcare use cases such as patient stratification, care pathway optimization, and forecasting
  • Familiarity with cloud platforms (e.g., AWS or Google Cloud)
  • Ability to turn ambiguous business questions into structured analysis
  • Effective communicator comfortable working across teams
  • Detail-oriented, proactive, and eager to learn
  • Team player with humility, curiosity, and a collaborative spirit
Responsibilities
  • Partner with cross-functional teams to scope and execute high-impact analytical projects
  • Build validated, documented, and QA-tested datasets from multiple source systems
  • Design and build dashboards and tools for clinical, product, and operational visibility
  • Conduct exploratory and statistical analyses to identify opportunities and insights
  • Own the full data lifecycle: requirements → pipeline → modeling → visualization → insight
  • Maintain high standards of data quality through robust documentation and testing
  • Clearly communicate insights and recommendations to both technical and non-technical stakeholders
  • Contribute to our internal knowledge base and support data literacy initiatives
Desired Qualifications
  • Prior experience in healthcare, health-tech, biopharma, or startup environments
  • Familiarity with clinical workflows or neurodegenerative care
  • Experience with value-based care, cohort analytics, and patient funnel metrics

Synapticure provides 24/7 telehealth for people with neurodegenerative diseases, delivering virtual neurology and behavioral health care to patients and caregivers from home. How it works: patients book and receive care from neurologists, behavioral health providers, and care coordinators via telehealth, with integrated behavioral health services and up-to-date science guidance to help understand options and access new treatments or clinical trials. Revenue comes from fees for telehealth sessions, paid by patients, insurers, or both. How it stands out: a specialized focus on ALS, Alzheimer’s, Huntington’s, and Parkinson’s, plus care coordination and behavioral health integration, backed by founders with personal ALS experience and doctors who are described as empathetic and knowledgeable. Goal: improve access to expert neurodegenerative care, support patients and caregivers, and connect them with treatments and clinical trials through a science-informed virtual platform.

Company Size

51-200

Company Stage

Series A

Total Funding

$31.1M

Headquarters

Chicago, Illinois

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • $25M Series A funding in 2023 fuels nationwide expansion and partnerships.
  • Joe Leinbach’s COO hire from Cityblock scales value-based payer contracts.
  • Michael J. Fox Foundation advisory accelerates Parkinson’s trial enrollment.

What critics are saying

  • Teladoc’s Teleneuro captures payer contracts, eroding Synapticure’s share by Q4 2026.
  • Amazon One Medical undercuts pricing with AI monitoring via Prime access in 2026.
  • UnitedHealth Optum launches identical model using Synapticure data by June 2026.

What makes Synapticure unique

  • Synapticure specializes in nationwide virtual neurology for ALS, Alzheimer’s, Parkinson’s, Huntington’s.
  • Co-founders Brian Wallach and Sandra Abrevaya bring personal ALS experience to empathetic care.
  • 95 NPS score reflects exceptional patient satisfaction from specialized, proactive support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Remote Work Options

Home Office Stipend

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

-3%
Modern Healthcare
Nov 21st, 2024
Top digital health funding: Morgan Health backs autism startup

In April 2023, Cortica received $75 million in a Series D funding round led by Optum Ventures.

FinSMEs
Nov 20th, 2024
Synapticure Raises $25M Series A

Synapticure, a Chicago, IL-based virtual care company dedicated to improving access and outcomes for patients and caregivers living with Alzheimer's and related dementias, Parkinson's, and other neurodegenerative diseases, raised $25M in Series A funding

Endpoints News
Nov 15th, 2024
SynaptiCure Raises $25M for Virtual Care

SynaptiCure has raised $25 million for its virtual approach to neurodegenerative disease care.

BioSpace
Oct 5th, 2023
National Institutes Of Health Awards $45.1 Million Ninds Grant For Cnm-Au8® Study In Alsfunding To Support Research And Expanded Access Of Investigational Drug In Als

SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH), to support an Expanded Access Protocol (EAP) for the Company’s investigational drug, CNM-Au8®, in amyotrophic lateral sclerosis (ALS). An EAP is also referred to as Compassionate Use and is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S. Food and Drug Administration (FDA)

Yahoo Finance
Sep 6th, 2023
Synapticure Welcomes Joe Leinbach As Chief Operating Officer And Expands Coverage To Additional Neurological Conditions

As the first nationwide virtual clinic specializing in neurodegenerative disease, Synapticure scales leadership team to meet the rapidly growing needs of patients, payers and providersCHICAGO, Sept. 6, 2023 /PRNewswire/ -- Synapticure , a virtual clinic transforming treatment and outcomes for individuals and their caregivers living with neurodegenerative diseases, announced Joe Leinbach has joined as the company's first Chief Operating Officer. Leinbach joins at a critical time for the company's expansion into additional neurodegenerative conditions including Alzheimer's and related Dementias, while creating new ways to expand patient access through innovative partnerships with health systems and health plans.A veteran of early stage value-based care innovators, Leinbach has driven growth and operational success in leadership roles at Cityblock Health and Evolent Health. His background includes scaling operations to serve individuals with complex physical and behavioral health needs, and structuring partnerships with payers and providers to improve patient costs and outcomes. Joe will lead the company's next phase of growth and efforts to implement innovative models that directly benefit patients and partners.Founded in 2021 by Brian Wallach and Sandra Abrevaya, the co-founders of I AM ALS , Synapticure's care teams now provide services to all 50 states + DC, providing specialized neurology care, integrated behavioral health, and care coordination to help patients and their caregivers navigate the complexities of neurodegenerative diseases. Through proactive, patient-centered support, Synapticure's patients have enrolled in clinical trials they otherwise wouldn't have accessed, were prescribed new medications and supplements changing their quality of life, avoided costly hospitalizations and ER visits, and received support for issues with medical equipment, insurance benefits and other care needs.Story continues"We've proven that patients and caregivers love working with Synapticure's specialized neurologists, as shown by our incredible NPS (Net Promoter Score) of 95

INACTIVE